Q3 2024 Holdings
Filed 2024-11-14 | 68 holdings | $6.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $22.6K | 350,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $49.3K | 10,000 | 0.0% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $540.2K | 209,361 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $799.5K | 50,000 | 0.0% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $1.7M | 635,276 | 0.0% |
| Allurion Technologies Inc | COM SHS | 02008G102 | $2.3M | 3,697,549 | 0.0% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $2.3M | 148,844 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $3.7M | 350,000 | 0.1% |
| Exagen Inc(XGN) | COM | 30068X103 | $4.7M | 1,511,866 | 0.1% |
| Acelyrin Inc | COM | 00445A100 | $4.8M | 978,310 | 0.1% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $4.9M | 3,256,102 | 0.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.5M | 125,000 | 0.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $6.3M | 200,000 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $7.4M | 900,000 | 0.1% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.4M | 742,500 | 0.1% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $7.5M | 4,567,717 | 0.1% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $11.4M | 502,856 | 0.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $11.6M | 575,000 | 0.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $12.4M | 1,133,787 | 0.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $16.4M | 786,353 | 0.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $16.8M | 1,454,273 | 0.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $18.3M | 666,667 | 0.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $19.1M | 741,656 | 0.3% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $19.8M | 3,261,496 | 0.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $20.5M | 863,389 | 0.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $22.3M | 3,327,129 | 0.3% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $22.6M | 400,000 | 0.3% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $28.6M | 1,705,960 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $30.0M | 14,946,420 | 0.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $40.4M | 5,591,700 | 0.6% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $42.2M | 8,206,159 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $45.4M | 1,850,648 | 0.7% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $47.6M | 1,135,256 | 0.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $48.1M | 3,787,347 | 0.7% |
| Glaukos Corp(GKOS) | COM | 377322102 | $50.3M | 386,291 | 0.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $50.7M | 1,344,074 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $54.6M | 7,378,548 | 0.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $57.2M | 4,652,285 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $68.5M | 2,782,329 | 1.0% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $75.6M | 4,098,955 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $95.8M | 3,258,360 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $109.3M | 1,968,002 | 1.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $112.2M | 3,412,486 | 1.6% |
| Immatics N.v(IMTX) | SHS | N44445109 | $114.1M | 10,000,000 | 1.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $114.5M | 2,645,703 | 1.7% |
| Radnet Inc(RDNT) | COM | 750491102 | $125.5M | 1,808,604 | 1.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $143.4M | 396,921 | 2.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $143.7M | 2,721,158 | 2.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $151.6M | 4,869,798 | 2.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $154.6M | 795,750 | 2.2% |